STAAR Surgical (NASDAQ:STAA) PT Lowered to $40.00
STAAR Surgical (NASDAQ:STAA – Free Report) had its price objective lowered by Piper Sandler from $45.00 to $40.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock. Several other research firms have also recently weighed in on STAA. Benchmark cut shares of […]